DeClue JE - Search Results

1

Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.

Ling BC, Wu J, Miller SJ, Monk KR, Shamekh R, Rizvi TA, Decourten-Myers G, Vogel KS, DeClue JE, Ratner N. Ling BC, et al. Among authors: declue je. Cancer Cell. 2005 Jan;7(1):65-75. doi: 10.1016/j.ccr.2004.10.016. Cancer Cell. 2005. PMID: 15652750 Free PMC article.

2

Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis.

Miller SJ, Li H, Rizvi TA, Huang Y, Johansson G, Bowersock J, Sidani A, Vitullo J, Vogel K, Parysek LM, DeClue JE, Ratner N. Miller SJ, et al. Among authors: declue je. Mol Cell Biol. 2003 Mar;23(6):2213-24. doi: 10.1128/MCB.23.6.2213-2224.2003. Mol Cell Biol. 2003. PMID: 12612091 Free PMC article.

3

cAMP-dependent protein kinase A is required for Schwann cell growth: interactions between the cAMP and neuregulin/tyrosine kinase pathways.

Kim HA, DeClue JE, Ratner N. Kim HA, et al. Among authors: declue je. J Neurosci Res. 1997 Jul 15;49(2):236-47. J Neurosci Res. 1997. PMID: 9272646

4

Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models.

DeClue JE, Heffelfinger S, Benvenuto G, Ling B, Li S, Rui W, Vass WC, Viskochil D, Ratner N. DeClue JE, et al. J Clin Invest. 2000 May;105(9):1233-41. doi: 10.1172/JCI7610. J Clin Invest. 2000. PMID: 10791998 Free PMC article.

5

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.

DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowy DR. DeClue JE, et al. Cell. 1992 Apr 17;69(2):265-73. doi: 10.1016/0092-8674(92)90407-4. Cell. 1992. PMID: 1568246

6

Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.

Kim HA, Rosenbaum T, Marchionni MA, Ratner N, DeClue JE. Kim HA, et al. Among authors: declue je. Oncogene. 1995 Jul 20;11(2):325-35. Oncogene. 1995. PMID: 7624147

7

Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model.

Li H, Velasco-Miguel S, Vass WC, Parada LF, DeClue JE. Li H, et al. Among authors: declue je. Cancer Res. 2002 Aug 1;62(15):4507-13. Cancer Res. 2002. PMID: 12154062

8

Rasp21 sequences opposite the nucleotide binding pocket are required for GRF-mediated nucleotide release.

Leonardsen L, DeClue JE, Lybaek H, Lowy DR, Willumsen BM. Leonardsen L, et al. Among authors: declue je. Oncogene. 1996 Nov 21;13(10):2177-87. Oncogene. 1996. PMID: 8950985

9

A ras effector domain mutant which is temperature sensitive for cellular transformation: interactions with GTPase-activating protein and NF-1.

DeClue JE, Stone JC, Blanchard RA, Papageorge AG, Martin P, Zhang K, Lowy DR. DeClue JE, et al. Mol Cell Biol. 1991 Jun;11(6):3132-8. doi: 10.1128/mcb.11.6.3132-3138.1991. Mol Cell Biol. 1991. PMID: 2038322 Free PMC article.

10

Inhibition of cell growth by lovastatin is independent of ras function.

DeClue JE, Vass WC, Papageorge AG, Lowy DR, Willumsen BM. DeClue JE, et al. Cancer Res. 1991 Jan 15;51(2):712-7. Cancer Res. 1991. PMID: 1985788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters